Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cincinnati, OH
NPI
1316041635
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
222 Piedmont Ave
Cincinnati, OH, 45219
Phone (513) 475-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
662 services
Medicare patients, 2024
247
Average age 69
Drug cost, 2024
$1.2M
2,915 prescriptions
Company payments, 2025
$63.81
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suman Jana was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 141 times for 102 patients. In total Suman Jana billed 662 services in 13 codes, and Medicare paid $37K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 141 | 102 | $12.13 | $1,711 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 109 | 91 | $12.15 | $1,324 |
| 99215 Office E&M - Established | Office | 90 | 71 | $98.34 | $8,851 |
| 99215 Office E&M - Established | Facility | 72 | 59 | $99.57 | $7,169 |
| 99214 Office E&M - Established | Office | 62 | 52 | $63.09 | $3,911 |
| 99214 Office E&M - Established | Facility | 60 | 51 | $58.70 | $3,522 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 25 | $59.70 | $2,925 |
| 99205 Office E&M - New | Office | 22 | 22 | $134.04 | $2,949 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $98.94 | $1,583 |
By year: 2022 $32K for 383 services; 2023 $32K for 403 services; 2024 $37K for 662 services.
Medicare prescription drug claims, 2024
In 2024, the drug Suman Jana prescribed most often to Medicare patients was Levothyroxine Sodium, with 426 prescriptions and refills. In total Suman Jana wrote 2,915 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 426 | 957 | 120 | $4,200 |
| Hydrocortisone Generic | 178 | 299 | 36 | $11K |
| Trulicity Dulaglutide | 155 | 211 | 28 | $208K |
| Metformin Hcl Er Metformin Hcl | 127 | 319 | 40 | $920 |
| Jardiance Empagliflozin | 122 | 198 | 28 | $113K |
| Alendronate Sodium Generic | 114 | 226 | 32 | $850 |
| Ozempic Semaglutide | 97 | 127 | 19 | $116K |
| Mounjaro Tirzepatide | 85 | 96 | 17 | $100K |
| Testosterone Generic | 80 | 99 | 16 | $12K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 74 | 179 | 27 | $9,618 |
| Metformin Hcl Generic | 69 | 128 | 13 | $236 |
| Testosterone Cypionate Generic | 65 | 77 | 11 | $1,417 |
| Methimazole Generic | 54 | 98 | 14 | $267 |
| Teriparatide Generic | 43 | 43 | Under 11 | $108K |
| Synthroid Levothyroxine Sodium | 37 | 101 | 14 | $2,328 |
Brand drugs: 1,331 claims; generic drugs: 1,380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suman Jana $63.81 ($63.81 in general payments such as food, travel and fees) from 2 companies. The largest payer was Astellas Pharma US Inc with $45.85.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.